Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
23 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-positive-topline-results-from-phase-3-triumph-program-of-tegoprazan-in-gerd-302435337.html
25 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-miudella-the-first-hormone-free-copper-intrauterine-system-ius-in-the-us-in-over-40-years-from-sebela-womens-health-inc-302384684.html
24 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sebela-womens-health-announces-publication-of-phase-3-pivotal-study-results-for-the-investigational-copper-175-mm2-intrauterine-device-iud-in-contraception-302359611.html
30 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sebela-womens-health-announces-further-positive-data-from-the-pivotal-phase-3-study-of-the-investigational-copper-175-mm-intra-uterine-device-iud-301971779.html
22 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-sebela-pharmaceuticals-suflave-a-new-colonoscopy-preparation-that-tastes-similar-to-a-sports-drink-301858251.html
21 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sebela-womens-health-shares-findings-from-a-real-world-cost-comparison-of-hormonal-and-non-hormonal-iud-use-among-privately-insured-individuals-in-the-us-301777224.html
ABOUT THIS PAGE